RecensMedical, Inc. (KOSDAQ:394420)

Market Cap	321.71B
Revenue (ttm)	8.83B +3,033.4%
Net Income	-19.12B
EPS	-2,890.00
Shares Out	10.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	409,049
Average Volume	1,874,111
Open	31,000
Previous Close	30,400
Day's Range	28,975 - 31,900
52-Week Range	17,550 - 39,900
Beta	n/a
RSI	71.81
Earnings Date	Jun 29, 2026

About RecensMedical

RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company’s products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 394420

Financial Performance

In 2025, RecensMedical's revenue was 8.83 billion, an increase of 41.05% compared to the previous year's 6.26 billion. Losses were -19.12 billion, 143.8% more than in 2024.